MedCap AB (publ) operates in the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MedCap AB (publ) with three other
financial institutions in Europe:
Gimv Investeringsmaatschappij Voor Vlanderen NV
sales of 142.34 million Euro [US$167.46 million]
of which 39%
HBM Healthcare Investments AG
(178.50 million Swiss Francs [US$182.52 million]
(689.60 million Swedish Kronor [US$84.56 million]
MedCap AB (publ) reported sales of SEK 851.67 million (US$104.43 million)
April of 2017.
increase of 4.3%
versus 2016, when the company's sales were SEK 816.92 million.
Despite this increase, sales are still
below the level achieved in 2015, when MedCap AB (publ)
reported sales of SEK 852.75 million.